Pathogenic mutations in the TAU-encoding MAPT gene underlying familial frontotemporal dementia (FTD), such as TAUP301L or TAUP301S, have supported the generation of multiple mouse models that recapitulate pathological and/or behavioural aspects of this disease. This evidence concerns the gene MAPT and frontotemporal dementia.